
Home » UCB SAYS INTERESTED IN ELI LILLY'S BELGIAN R&D SITE
UCB SAYS INTERESTED IN ELI LILLY'S BELGIAN R&D SITE
Belgian pharmaceutical company UCB SA said Monday it may be interested in Eli Lilly & Co.'s (LLY) research and development center at Mont-Saint-Guibert in Belgium.
Easy
Bourse
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
08Sep
-
13Sep
-
14Sep
-
15Sep
-
20Sep
-
21Sep